Abbott and Pierre Fabre Target Cancer in Antibody Pact

By Taskin Ahmed

Pharma Deals Review: Vol 2010 Issue 2 (Table of Contents)

Published: 10 Feb-2010

DOI: 10.3833/pdr.v2010.i2.1312     ISSN: 1756-7874

Section: Research & Development

Fulltext:

Abstract

Abbott has bolstered its oncology pipeline by signing an exclusive worldwide licensing agreement with Pierre Fabre SA...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details